Your browser doesn't support javascript.
loading
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII).
Ji, Linong; Wan, Hailong; Wen, Binhong; Wang, Xueying; Wang, Junfen; Bian, Rongwen; Pang, Wuyan; Tian, Jian; Wang, Yan; Bian, Fang; Gao, Zhengnan; Condoleon, Alex; Feng, Wei; Zhang, Xia; Cui, Nan.
Afiliação
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
  • Wan H; Department of Endocrinology, Panjin Central Hospital, Panjin, China.
  • Wen B; Department of Endocrinology, People's Hospital of Liaoning Province, Liaoning, China.
  • Wang X; Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, China.
  • Wang J; Department of Endocrinology, Second Hospital of Shijiazhuang, Shijiazhuang, China.
  • Bian R; Department of Endocrinology and Metabolism, Jiangsu Province Institute of Geriatrics, Nanjing, Jiangsu, China.
  • Pang W; Department of Endocrinology and Metabolism, Huaihe Hospital of Henan University, Kaifeng, Henan, China.
  • Tian J; Department of Endocrinology and Metabolism, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China.
  • Wang Y; Department of Endocrinology, Second Hospital of Chaoyang City, Chaoyang City, China.
  • Bian F; Department of Endocrinology, Cangzhou People's Hospital, Cangzhou, China.
  • Gao Z; Department of Endocrinology and Metabolism, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, Liaoning, China.
  • Condoleon A; Sanofi, Paris, France.
  • Feng W; Sanofi, Shanghai, China.
  • Zhang X; Sanofi, Shanghai, China.
  • Cui N; Sanofi, Shanghai, China.
Diabetes Obes Metab ; 22(5): 838-846, 2020 05.
Article em En | MEDLINE | ID: mdl-31944546

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Diabetes Obes Metab Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Diabetes Obes Metab Ano de publicação: 2020 Tipo de documento: Article